Bufotalin was reported to improve GPX4 ubiquitination and degradation, increase intracellular lipid ROS and Fe2+ levels, induce the ferroptosis of NSCLCs, and suppress tumor growth in vivo [40]. The gene discussed is GPX4; the disease is neoplasm.